Focus on Patients

  1. What's A Better Tactic For Patient Recruitment — "Unreasonable Hospitality" Or The Same Old? 10/10/2024

    When it comes to patient recruitment, which is a better strategy: sticking to the same old routine or becoming unreasonably hospitable? Consultant Ross Jackson explores both options.

  2. How One Biotech Is Using FDA 505(b)(2) To Get Drugs To Patients Quicker And Cheaper 10/9/2024

    Terran Biosciences CEO Sam Clark, MD, Ph.D. explains how his team is leveraging the 505(b)(2) regulatory pathway to get its new schizophrenia drug to patients quickly and affordably. 

  3. Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) 10/2/2024

    Learn how Rezolute successfully led its investigational drug for treating congenital hyperinsulinism (cHI) through a compassionate use program.

  4. Compassionate Use Program (CUP) Benefits & Strategies In Rare Disease 10/2/2024

    In part two of this series, Rezolute discusses the benefits of continuing patient care with a compassionate use program (CUP) and shares best practices for implementing one.

  5. Why Diversity Of Geography Matters: A Call To Drive Rural Patient Enrollment 9/30/2024

    To make clinical trials more inclusive, CROs and sponsors must intentionally expand to different — including rural — communities to recruit more diverse patients.

  6. Why Industry Must Design Alzheimer's Trials To Include People With Down Syndrome 9/24/2024

    The recruitment and enrollment of people with Down syndrome involve special challenges, but these challenges can be addressed with proper planning and education.

  7. Patients Get More Mileage With Free Flights To Far-Flung Clinical Trial Sites 9/20/2024

    LifeLine Pilot Executive Director Lindsey Kerr shares the impact free medical flights can have on patients participating in clinical trials far from home.

  8. Why Is The Reality Of Patient Engagement Not Living Up To Its Theory? 9/17/2024

    Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.

  9. If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late 9/17/2024

    Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).

  10. Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials? 9/13/2024

    Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.